DTC – Virtual DTC Educational Series: August 18, 2020
Virtual DTC Educational Series: August 18, 2020
Click here to purchase this OnDemand Webinar
Master Class Credits: 1 DTC Credit
A Washington Insider Update
JIM DAVIDSON, POLSINELLI
While there has been little legislative activity across the board, that does not mean that DTC advertising is not still under pressure. Ad restrictions for DTC are still being discussed and taxes on advertising are pending at the state level, including in Maryland and New York. Join Jim Davidson as he shares the latest happenings from Washington, DC.
COVID-19 & Impacts on Diabetes Patients
MEGHAN OATES-ZALESKY, INCROWD
With the outbreak of the novel coronavirus (COVID-19) in the US, InCrowd has been conducting tracking research to understand the impact of the pandemic on several healthcare stakeholder groups. The disruption caused by COVID-19 has taken a particular toll on high-need patients. In this latest installment, InCrowd has analyzed data from PCPs, endocrinologists, Type-1 diabetes patients, and Type-2 diabetes patients to learn how they have been affected by the virus when it comes to their disease management.
Safety First: In-Office Engagement in a COVID-19 World
NICK MAGRUDER, FRIENDMEDIA
The patient journey is changing, and we are experiencing a huge acceleration in all things digital for healthcare providers. In-office patient education and engagement is a vital component for safety and growth. This session will help you learn how to curate and display your most vital content at reception and in the exam room so you can still tell your story, something patients want to hear.
The Impact of COVID-19 on Point-of-Care Engagement
DAVID LINETSKY, PHREESIA
SARAH BAST, PUBLICIS HEALTH MEDIA
The COVID-19 pandemic has led to steep decreases in patient visits as patients stayed home and deferred non-urgent care. Healthcare organizations responded by quickly pivoting to virtual visits and implementing technology-enabled workflows that reduced contact between patients and staff during in-person visits. Those dramatic workflow shifts shed light on the fact that more than ever before, technology platforms need to be flexible, adaptable, and meet patients where they are. These tools must be seamlessly integrated into providers’ workflow and deliver relevant, personalized content to patients on the device they prefer, whether they are in an in-person or virtual care setting. This session will explore the importance of being patient-centric and why aligning with adaptable tools will position brands for success.
Human Connections and Scientific Empathy Drive Adherence and Rx Lift
BARBARA READ, PLEIO
MICHAEL OLEKSIW, PLEIO
PETER WEISSBERG, INTOUCH SOLUTIONS
COVID-19 put a giant magnifying glass on patient adherence and how behavioral science expertise, data, and empathy can improve patient compliance and experience while saving lives and millions of dollars. During normal times, an estimated $300 billion is lost in revenue due to non-adherence, making non-adherence to medications one of the largest and most expensive disease categories. Additionally, non-adherence can account for more than 125,000 deaths annually and 25% of hospital admissions. Learn how human connections and empathy produces healthy outcomes for your patients. This discussion will provide advice on how to team with the right ad agency to address adherence issues, develop successful patient support programs, and how to create and measure effective patient engagement tools.
Helping Patients with Chronic Conditions During the Aftermath of COVID-19
FLOREN ROBINSON PRESSMAN, ACCENTURE INTERACTIVE
SARAH KRÜG, CANCER 101 & HEALTH COLLABORATORY
WHITNEY BALDWIN, ACCENTURE INTERACTIVE
As states are starting to fluctuate between opening and closing due to COVID-19, chronic condition patients are struggling to understand what the “new normal” will look like. In this new world, patients now have different expectations of pharma. Drawing from Accenture’s recent study, “How COVID-19 will permanently alter patient behavior”, this session will share key findings to help you better understand human end-to-end needs and how we can best support patients. We will look at important aspects of the patient journey and identify ways to effectively communicate and engage with them during this unprecedented time, addressing the following questions:
- How can we help patients to get the best possible care while keeping them safe?
- How can we engage with them and provide the support and resources they need to survive?
- How can we create an ecosystem of care services that can connect the patient and their family, caregivers, and care team?
Rewriting the Rules: How COVID-19 Has Changed Patient Priorities for Expertise
ERIC PEACOCK, MYHEALTHTEAMS
New consumer research underscores that COVID-19 has changed the way patients want to engage – with their healthcare providers, health information sources, and their peers. Chronic conditions do not “shelter in place,” yet many people are no longer going to regular appointments or in-person support groups. As patients move out of point-of-care and into virtual spaces, innovative pharma marketers are transforming their approach to patient education and patient activation. They are engaging patients in social networks by providing actionable tips for managing health at home and expert advice for maximizing virtual conversations with doctors. This approach is delivering some of the highest patient engagement in years. Gain insight into unmet patient needs and the on-demand resources that are bringing condition-specific medical expertise into their homes, at scale. This session will also address the need to prioritize privacy as more patient information lives in more places online. Learn how to navigate the requirements of MLR, AE reporting, and more in social.